Financhill
Back

BioNTech SE 10K Form

Sell
21

BNTX
BioNTech SE

Last Price:
91.42
Seasonality Move:
29.48%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BNTX News And Ratings

See the #1 stock for the next 7 days that we like better than BNTX

BNTX Financial Statistics

Sales & Book Value

Annual Sales: $18.26B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $88.46
Price / Book: 1.05

Profitability

EPS (TTM): 11.53840
Net Income (TTM): $2.84B
Gross Margin: $13.48B
Return on Equity: 14.21%
Return on Assets: 11.96%

BioNTech SE Earnings Forecast

Key BioNTech SE Financial Ratios

  • The Gross Profit Margin over the past 6 years for BNTX is 73.82%.
  • The Selling, General & Administrative Expenses for BNTX have been equal to 3.14% of Gross Profit Margin.
  • The Research & Development expenses have been 134.16% of Revenue.
  • The Interest Expense is 0.17% of Operating Income.
  • The Net Earning history of BNTX is 54.50% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 3 years.

BioNTech SE Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Healthcare
Current Symbol: BNTX
CUSIP: 09075V
Website: biontech.de

Debt

Debt-to-Equity Ratio: 0.01
Current Ratio: 10.37
Quick Ratio: 9.99

Price-to-Earnings

Trailing P/E Ratio: 2.33
Forward P/E Ratio: 0

BNTX Technical Analysis vs Fundamental Analysis

Sell
21
BioNTech SE (BNTX) is a Sell

Is BioNTech SE a Buy or a Sell?

  • BioNTech SE stock is rated a Sell
    The current BioNTech SE [BNTX] share price is $92.73. The Score for BNTX is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.